Detalhe da pesquisa
1.
Impact of Implantation Technique and Plaque Morphology on Strut Embedment and Scaffold Expansion of Polylactide Bioresorbable Scaffoldã- Insights From ABSORB Japan Trial.
Circ J
; 80(11): 2317-2326, 2016 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27725525
2.
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.
Am Heart J
; 167(2): 133-40, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24439973
3.
Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
Heart Vessels
; 27(4): 360-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21725668
4.
One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent.
Catheter Cardiovasc Interv
; 77(6): 809-17, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20853436
5.
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study.
EuroIntervention
; 16(14): 1187-1194, 2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062697
6.
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial.
EuroIntervention
; 15(15): e1366-e1374, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719981
7.
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
JACC Cardiovasc Interv
; 13(7): 820-830, 2020 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273094
8.
Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent: Insights From the DESSOLVE III All-Comers Randomized Trial.
Circ Cardiovasc Interv
; 13(6): e008737, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466676
9.
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).
Am J Cardiol
; 127: 1-8, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418717
10.
A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.
JACC Cardiovasc Interv
; 11(3): 275-283, 2018 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29413242
11.
Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
Expert Rev Med Devices
; 14(5): 325-334, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402204
12.
The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
JACC Cardiovasc Interv
; 10(5): 489-499, 2017 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28279316
13.
One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
J Invasive Cardiol
; 29(8): 253-258, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756418
14.
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
EuroIntervention
; 12(8): e998-e1008, 2016 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27721215
15.
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging.
EuroIntervention
; 12(5): e574-83, 2016 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27497357
16.
Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus-Eluting Bioresorbable Vascular Scaffold.
J Am Heart Assoc
; 4(11)2015 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553215
17.
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.
PLoS One
; 10(9): e0138459, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26389595
18.
Distal embolization of hydrophilic-coating material from coronary guidewires after percutaneous coronary interventions.
Circ Cardiovasc Interv
; 8(2): e001816, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25582439
19.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.
EuroIntervention
; 15(7): 603-606, 2019 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147304
20.
Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
EuroIntervention
; 6(7): 819-25, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252015